CN114634938A - Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis - Google Patents
Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis Download PDFInfo
- Publication number
- CN114634938A CN114634938A CN202210212625.9A CN202210212625A CN114634938A CN 114634938 A CN114634938 A CN 114634938A CN 202210212625 A CN202210212625 A CN 202210212625A CN 114634938 A CN114634938 A CN 114634938A
- Authority
- CN
- China
- Prior art keywords
- folic acid
- strain
- fol
- gene
- lactobacillus plantarum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 title claims abstract description 91
- 235000019152 folic acid Nutrition 0.000 title claims abstract description 47
- 239000011724 folic acid Substances 0.000 title claims abstract description 47
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 41
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 41
- 229960000304 folic acid Drugs 0.000 title claims abstract description 41
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 41
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 title abstract description 7
- 230000001580 bacterial effect Effects 0.000 abstract description 11
- 239000013612 plasmid Substances 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 229940014144 folate Drugs 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000006801 homologous recombination Effects 0.000 abstract 1
- 238000002744 homologous recombination Methods 0.000 abstract 1
- 101150044508 key gene Proteins 0.000 abstract 1
- 101150058143 folKE gene Proteins 0.000 description 36
- 238000003209 gene knockout Methods 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 13
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 238000012795 verification Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000009630 liquid culture Methods 0.000 description 6
- 230000003068 static effect Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 229960003276 erythromycin Drugs 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001976 enzyme digestion Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000019159 vitamin B9 Nutrition 0.000 description 3
- 239000011727 vitamin B9 Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- -1 citrate-uranium acetate Chemical compound 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 206010009260 Cleft lip and palate Diseases 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000016653 cleft lip/palate Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a lactobacillus plantarum (A)Lactobacillus plantarum) GenefolNew application of KE, namely application of KE in folic acid biosynthesis, and genesfolKE is shown as SEQ ID NO 1; the invention constructs a temperature-sensitive plasmid pFED760 through a homologous recombination technologyfolKnockout strain delta of KE genefolKE, observing the cell shape and the growth state of the strain, measuring the folate production capability of the strain, and displaying that compared with the wild strain, the DeltafolThe folic acid production amount of the KE bacterial strain is obviously reduced,folthe KE gene plays a key role in folic acid synthesis, and the invention is favorable for improving the position of the key gene in folic acid synthesisThe yield of folic acid lays the early foundation for the development of folic acid food.
Description
Technical Field
The invention belongs to the field of folic acid biosynthesis application, and particularly relates to application of a lactobacillus plantarum gene folKE in lactobacillus plantarum folic acid biosynthesis.
Background
Folic acid (also called pteroylglutamic acid), vitamin B9, anti-anemia factor, vitamin M, vitamin Bc, etc., is a water-soluble vitamin. Folic acid is yellow crystal, slightly soluble in water, insoluble in ethanol, and easily decomposed by light. Folate deficiency causes a number of diseases, commonly seen as megaloblastic anemia, cleft lip and palate, and depression.
Natural folic acid, although widely available, is not satisfactory for human consumption on a daily basis, particularly in pregnant women, due to its own instability and high rate of loss during cooking. In addition, due to geographical location factors, more people living in remote areas are less able to ingest daily needs. Therefore, the development of folic acid-rich foods or related preparations is the best solution to the problem.
Folic acid can be synthesized by industrial production, but in order to protect the environment, a plurality of plants are shut down, and thus it is imperative to seek an environmentally friendly synthesis method. Biosynthetic folic acid has incomparable advantages, most notably natural folic acid exists mostly in the form of pteroylpolyglutamic acid, and is not easy to form dependency on folic acid compared with pteroylmonoglutamic acid of synthetic folic acid. Since the liver is bound to be burdened if dependency is formed, naturally synthesized folic acid is required to solve the problem of insufficient folic acid intake.
Folic acid synthesized by lactobacillus plantarum is more competitive in the market due to its safety, but also suffers from a problem of low yield of folic acid. Therefore, it is necessary to explore the action mechanism of the key enzyme gene for the biosynthesis of folic acid by lactobacillus plantarum, so as to lay the foundation for the development of folic acid food in the future.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides the application of a Lactobacillus plantarum (Lactobacillus plantarum) gene folKE gene, namely the application of the gene folKE in Lactobacillus plantarum folic acid synthesis, wherein the nucleotide sequence of the gene folKE is shown as SEQ ID NO. 1.
The invention clones the upstream and downstream homologous arms (991 bp and 1000 bp respectively) of gene fol KE from Lactobacillus plantarum YM-4-3 by the following primers:
up-KEF: 5'-GCGTCGACACGCACTTTTTTCGGTTCC-3' and up-KER: 5'-CCTGTATCCACTCAATCACCTAACTCACTCACATTTCT-3';
down-KEF: 5'-AGAAATGTGAGTGAGTTAGGTGATTGAGTGGATACAGG-3' and down-KER: 5'-CGGAATTCGCCACTAGTGCTGCCATGC-3', respectively;
the upstream and downstream homologous arms of folKE gene and temperature sensitive plasmid pFED760 are respectively cut by SalI and EcoRI and then connected to obtain a knockout vector, the knockout vector is then electrically transferred into Lactobacillus plantarum YM-4-3 competent cells, a knockout strain delta folKE is obtained after bacterial liquid verification is selected, strain growth states and folic acid yields of wild type strain YM-4-3 and knockout strain delta folKE are compared through experiments, and therefore the folKE gene plays a key role in strain growth state and folic acid synthesis.
Compared with the prior art, the invention has the following advantages:
1. the gene is from food-borne lactobacillus plantarum, has high safety and can be used in the field of later-stage food fermentation;
2. the food-borne lactobacillus plantarum is used for generating the folic acid, so that the production cost is reduced, and the economic benefit can be improved;
3. compared with the industrial synthesis of folic acid, the biological synthesis of folic acid has better environmental friendliness;
4. the folKE gene plays a key role in folic acid synthesis, provides a certain theoretical basis for research and development of folic acid synthesis functional foods, is simple to operate, and is suitable for industrial production and market popularization and application.
Drawings
FIG. 1 shows PCR verification of bacterial liquid of folKE gene knockout strain of the present invention, wherein lane M: BM5000 DNA marker; lanes 1, 2, 4 and 5: knock out the genomic DNA of the strain folKE as a PCR product of the template; lane 3: taking the genome DNA of the lactobacillus plantarum wild strain as a PCR product of a template; 6 is blank control;
FIG. 2 is a scanning and transmission electron microscope image of a wild strain and a knock-out strain of Lactobacillus plantarum of the present invention; a: scanning electron microscope images of wild strains; b: knocking out a strain fol KE scanning electron microscope picture; c: transmission electron microscope picture of wild type strain; d: knocking out a strain fol KE transmission electron microscope picture;
FIG. 3 shows the growth status of the bacterial liquid of the wild Lactobacillus plantarum strain (A) and the Δ folKE (B) knockout strain of the invention;
FIG. 4 shows the OD of the wild type strain and the fated strain of Lactobacillus plantarum of the present invention600And folic acid content.
Detailed Description
The present invention is further illustrated in detail below with reference to the drawings and examples, but the scope of the present invention is not limited to the above description, and reagents and methods used in the examples are, unless otherwise specified, conventional reagents and conventional methods. The temperature sensitive plasmid pFED760 was gifted by Philippines J Federle, university of Illinois; the results in the following examples are all the average values of three replicates unless otherwise specified.
Example 1: cloning of upstream and downstream homology arms of gene folKE
1. Upstream and downstream homology arms for PCR amplification
Extracting total DNA of a food-borne lactobacillus plantarum YM-4-3 genome by using a CTAB/enzyme method, taking the extracted genome as a template, and respectively amplifying upstream and downstream homologous arms of a folKE gene by using a primer pair up-KEF (5'-GCGTCGACACGCACTTTTTTCGGTTCC-3', underlined is SalI enzyme cutting site) + up-KER (5'-CCTGTATCCACTCAATCACCTAACTCACTCACATTTCT-3') and down-KEF (5'-AGAAATGTGAGTGAGTTAGGTGATTGAGTGGATACAGG-3') + down-KER (5'-CGGAATTCGCCACTAGTGCTGCCATGC-3', underlined is EcoRI enzyme cutting site), wherein a PCR reaction system and amplification conditions are as follows:
(1) PCR reaction system
(2) PCR amplification conditions
Pre-denaturation at 95 ℃ for 3 min; denaturation at 95 ℃ for 15 s; annealing at 60-63 ℃ for 30 s; extending for 1min at 72 ℃; circulating for 30 times; extending at 72 ℃ for 5min, storing at 12 ℃ (upstream annealing temperature 60 ℃ and downstream annealing temperature 63 ℃), taking 5 mu L after the reaction is finished, and carrying out electrophoretic analysis in 1% agarose gel, wherein the nucleotide sequences of the upstream and downstream homologous arms of the folKE gene are shown as SEQ ID NO: 2 and SEQ ID NO: 3.
2. Cloning and sequencing of gene knockout fragment
1 mu L of each downstream homology arm PCR product is taken as a template, up-KEF and down-KER are taken as primers, and overlapping PCR is carried out according to the PCR reaction system and the amplification conditions (the annealing temperature is 61 ℃, and the extension time is changed to 2 min). The PCR product (i.e., the knockout fragment) of the expected size was recovered by cutting the gel and ligated into the pMD19-T vector according to the TA cloning kit instructions of Dalibao Bio (China). The ligation products were introduced into E.coli DH 5. alpha. competent cells by heat shock transformation and plated on Amp-LB plates. After overnight culture at 37 ℃, randomly selecting 10-15 single colonies, extracting plasmids in cells, carrying out enzyme digestion verification by using SalI and EcoRI, and sending positive plasmids to a sequencing company for sequencing.
Example 2: construction of fol KE Gene knockout vector
Synchronously digesting the gene knockout fragment with correct sequencing and the temperature-sensitive plasmid pED 760 by using restriction enzymes SalI and EcoRI respectively, wherein the digestion system is as follows: SalI, 1 muL; EcoRI, 1 μ L; 10 XH buffer, 2 μ L; knocking out a fragment or pFAD 760, 10-16 muL; adding sterilized deionized water to 20 mu L, and carrying out enzyme digestion at 37 ℃ for 4 h; and (3) recovering the enzyme digestion product, adding the sample according to the molar ratio of the target gene to the vector = 4: 1-2: 1, adding T4 DNA ligase, and connecting for 12-16 h at 16 ℃. The ligation products were introduced into E.coli DH 5. alpha. competent cells using heat shock transformation and subsequently plated onto erythromycin-LB solid plates. After overnight culture at 28 ℃, plasmids in 10-15 single colony cells are extracted and subjected to enzyme digestion verification by SalI and EcoRI to obtain positive plasmids which are named as pFED 760-folKE.
Example 3: folKE Gene knock-out Strain construction
1. Introduction of folKE gene knockout vector into lactobacillus plantarum competent cells
Lactobacillus plantarum competent cells were prepared as follows: thawing Lactobacillus plantarum YM4-3 strain, inoculating to MRS broth culture medium at 4 ‰ inoculum size, standing at 37 deg.C for 12h, inoculating 1mL into 50mL MRS broth culture medium containing 2.5% glycine, culturing for 6h, and stopping culturing when OD600 value reaches 0.6. Centrifuging at 4 deg.C and 4000 rpm/min for 10min to collect bacterial liquid, washing with 25mL sterilized sterile water twice, centrifuging again, and performing low temperature operation. Discarding the supernatant, resuspending the cells in 0.05mol/L EDTA solution, ice-cooling for 5min, adding 25mL ice-cold sterilized water, centrifuging at 4 deg.C and 8000rpm/min for 5min, washing with 25mL ice-cold sterilized water again, centrifuging with 25mL shock buffer (0.5mol/L sucrose, 10% glycerol) at 4 deg.C and 8000rpm/min for 10min, repeating the above steps once, finally resuspending the cells in 0.8mL shock buffer, packaging the above mixture in 90 μ L volumes into sterilized 1.5mL centrifuge tubes (handling on ice when dispensing is noted), and storing at-80 deg.C.
Adding 10 mu L of gene knockout carrier pFED760-folKE into 90 mu L of lactobacillus plantarum YM-4-3 competent cells, gently mixing uniformly, carrying out ice bath for 5min, and then transferring into a precooling electric shock cup (with the distance of 2mm) for electric shock. Quickly adding 900 mu L of fresh MRS culture solution into an electric rotating cup after electric shock is finished, slightly blowing and beating the mixture by using a gun head, uniformly mixing the mixture, transferring the mixture into a sterile 1.5mL centrifuge tube, and statically culturing the mixture at the temperature of 28 ℃ for 2.5-3 h to resuscitate cells; after the culture, the bacterial liquid is centrifuged for 3min at 8000rpm, 900 mu L of supernatant is discarded, the residual supernatant is used for resuspending the thalli, the thalli is coated on an MRS solid plate containing 5 mu g/mL of erythromycin, and the culture is carried out at the temperature of 28 ℃ in a standing way.
2. Screening and verification of folKE gene knockout strain
Randomly selecting 2-3 single colonies, transferring the single colonies into an MRS liquid culture medium containing 5 mu g/mL erythromycin, and standing and culturing at 28 ℃ until bacterial liquid OD600When the concentration is 0.2-0.3 ℃, transferring the bacterial liquid to 37 ℃, continuing to perform standing culture overnight, and diluting the cultured bacterial liquid by 10 percent3~105Spreading the multiplied cells on an MRS solid plate containing 5 mug/mL erythromycin, performing static culture at 37 ℃ for 24 hours, selecting monoclonals, inoculating the monoclonals into 1mL of MRS liquid culture medium containing 5 mug/mL erythromycin, performing static culture at 37 ℃ overnight, inoculating 1% of culture liquid into the MRS liquid culture medium without antibiotics, performing static culture at 28 ℃ overnight, and then diluting the culture liquid by 10%3~105Coating on MRS solid plate without antibiotic, static culturing at 37 deg.C until single colony grows out, picking out smaller single colonyAnd scribing on MRS solid plates containing 5 mug/mL of erythromycin and containing no antibiotics in a one-to-one correspondence manner, carrying out static culture at 37 ℃ for 24h, and selecting colonies which cannot grow on MRS agar plates containing antibiotics and can grow on plates containing no antibiotics for carrying out bacteria liquid PCR verification. PCR verification of bacterial liquid: pFED760 FF: 5'-CTAAAAATCAGTTTCATCAAGCAAT-3', respectively; folKE-RR: 5'-CATCGCAGCCGTGGTCATA-3', respectively; the PCR fragment of the wild strain was 570bp larger than that of the knockout strain, and the result is shown in FIG. 1.
Example 4: detection of cell morphology and growth state of delta folKE strain
1. Cell morphology observation
1.5mL of cultured Lactobacillus plantarum wild strain and gene knockout strain delta folKE are respectively taken, centrifuged for 5min at 5000rpm, after supernatant is discarded, thalli are firstly fixed by 3.5% glutaraldehyde stationary liquid, and then an electron microscope observation sample is processed according to the following steps.
(1) Preparation of scanning electron microscope sample
Glutaraldehyde pre-fixation followed → phosphate buffer washing → 1% osmic acid fixation → phosphate buffer washing → different gradient ethanol dehydration → tert-butanol replacement → critical point freeze drying → ion sputtering gold → scanning electron microscopy.
(2) Preparation of sample for projection electron microscope
Glutaraldehyde pre-fixation and post-fixation → phosphate buffer washing → 1% osmic acid fixation → phosphate buffer washing → ethanol, acetone stepwise dehydration → epoxy resin 618 permeation → embedding → semithin section → optical lens localization, block modification → Leica-R microtome section → lead citrate-uranium acetate double staining → transmission electron microscopy observation.
As shown in FIG. 2A, the wild-type strain cells were rod-shaped, smooth in surface, intact in shape, and without separation of the cytoplasmic wall. Compared with lactobacillus plantarum wild strains, scanning electron microscopy shows that cytoplasm of the gene knockout strain delta folKE is shriveled, plasmolysis occurs, the adhesion among strains is enhanced, and some thalli are irregular rod-shaped and even sunken (figure 2B); in addition, the transmission electron microscope result shows that the cell wall of partial cells of the gene knockout strain delta folKE is thinned, the cell contents are condensed into particles, and even some cell walls are cracked, the contents leak (fig. 2C and 2D); these results indicate that the folKE gene knockout alters the cellular structural morphology, and that the folKE gene is closely associated with the lactobacillus plantarum cellular morphology maintenance.
2. Observation of macroscopic bacteria liquid state
Inoculating the activated lactobacillus plantarum wild type strain and the gene knockout strain delta folKE into 5mL of fresh MRS liquid culture medium according to the same inoculation amount, and performing static culture at 37 ℃ for 18 h; the growth condition of the strain is shown in figure 3, compared with the wild strain, the growth speed of the knocked-out strain delta folKE is obviously reduced, and the thallus is obviously settled at the bottom of the liquid, namely the thallus is precipitated to grow, so that the growth state of the strain is changed after the folKE gene is knocked out.
3. Gene knockout strain delta folKE dynamic growth monitoring
After the strains were activated and counted, the number of the strains was 1.0X 106Inoculating the CFU/mL inoculum size into 300mL fresh MRS liquid culture medium, standing at 37 deg.C for 120h, sampling every 2h, and measuring OD with spectrophotometer600The results are shown in FIG. 4 by comparison of OD600It was found that the gene knockout strain Δ folKE grew slowly and the OD of the wild-type YM-4-3 strain600Rises sharply during 8h-12h, remains relatively stable after 24h, OD600Is 7.709. OD of knockout strain delta fol KE600The strain rises steadily until 36h, the rising amplitude is relatively small, and then the strain fluctuates slightly up and down, is basically maintained at about 2.5 and has a large difference with the wild strain.
Example 5: determination of folate content of gene knockout strain delta folKE
Activating wild strain and gene knockout strain delta folKE of Lactobacillus plantarum at a ratio of 1.0 × 107 Inoculating CFU/mL into 30mL of FACM liquid culture medium, standing at 37 ℃ for 72h, taking out 5mL of bacterial liquid every 12h, carrying out light-shielding ultrasonic crushing treatment for 20min, centrifuging at 12000rpm for 10min, and then taking 1mL of supernatant for freeze drying; then 1mL of 1% ammonia water was added for dissolution, sonicated for 5min, centrifuged at 12000rpm for 10min, and the supernatant was used for HPLC analysis of the folate content.
(1) Chromatographic conditions are as follows: chromatography column, Waters ACQUITY UPLC BEH Amide column (2.1 mm × 100mm, 1.7 μm); the mobile phase is methanol (containing 5mmol/L ammonium formate) and water (containing 5mmol/L ammonium formate); gradient elution: 0-5 min, 98% -95% methanol; 5-10 min, 95% -55% methanol; 10-12 min, 55% methanol; 12-14 min, 55% -98% methanol; 14-20 min, 98% methanol. The flow rate is 0.2 mL/min, the column temperature is 35 ℃, and the sample injection amount is 5 muL.
(2) Mass spectrum conditions: 4500QTrap mass spectral parameters were set as follows: the method comprises the following steps of detecting by using a positive ion mode, wherein the ion source is an ESI ionization source, and the detection is carried out by using a gas curtain gas (CUR) 25, a collision gas (CAD) and the like, wherein the ion source gas is 1 (GS 1) 45, the ion source gas is 2 (GS 2) 50, the electrospray voltage is 5500V, the heater temperature is 350 ℃.
As can be seen from FIG. 4, the folic acid content in the fermentation broth of the Lactobacillus plantarum wild type strain and the gene knockout strain delta folKE is increased or decreased in a fluctuating manner; the subsequent fluctuation of the folate content of the gene knockout strain delta folKE is always lower than that of the wild strain, and the result shows that the folKE gene knockout causes slow growth, and the OD is verified before600The change of (3) seriously affects the folic acid yield of the strain, and proves that the folKE gene plays a key role in the synthesis of the lactobacillus plantarum folic acid, so that the folic acid yield can be improved by changing the folKE gene subsequently, and a theoretical basis is provided for the industrial application of the lactobacillus plantarum YM-4-3 strain and metabolites thereof.
Sequence listing
<110> university of Kunming science
<120> application of Lactobacillus plantarum gene fol KE in folic acid biosynthesis
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 570
<212> DNA
<213> Lactobacillus plantarum YM4-3 (Lactobacillus plantarum YM 4-3)
<400> 1
atgattgatg agaagaacca agcaaagatt gagcatgcag tacgagaaat tttaagtgca 60
gttggtgaag atcctgaccg accgggatta gtagaaacac cagcacgggt tgcacgaatg 120
tatgcggaag ttttcgctac taagaccgcc gcaccatttg ataattataa actgttcaag 180
gttgagcatc cgactgaaat ggtattactt aaggatattc cattctattc gatgtgtgag 240
catcaccttt tgccgttttt tggcacggtt caagttgctt atgtgccgca gcatgaacaa 300
gtgattggct tgagtaagat tcctcgcttg attgactatt gcagtcaaca gccgaacgtt 360
caggagcggt tgacagtttc cattgcaaca gaattacaac gaattcttga cccggctggg 420
atcgcggtct caatcacggc gcggcacatg tgcatggaga tgcggggtgt tagcaaaccg 480
ggtgtgcata cggaaagtag ctattacagt ggtcaattca agacggattt agacttgaaa 540
cgagaattct tacagcgaat cgcaaagtag 570
<210> 2
<211> 991
<212> DNA
<213> Lactobacillus plantarum YM4-3 (Lactobacillus plantarum YM 4-3)
<400> 2
acgcactttt ttcggttccc gaacgattgc tagtttttat ggggttattt ggctgattac 60
tatcatattg agcgtccttc atgctatgat tataagtaaa aatgagcaag aaagaggctg 120
ggatacttat gggcatgatt cgaattaata atttacgctt tcacacgttt aacggggtac 180
ttccggaaga acggcgtaat ggtcaacaac tagggctaga tattgccatt aaatatccta 240
tcgaaaccaa ggttcaacac gatgacgttc acgagaccat caattacgcg gcggtccgta 300
acgtggtcga tgaatttgta acgacccatt catacaagtt gattgaatcg ctagctaacc 360
acttattgca gacgttattg acaagttttc ccgcggcgga tgcaatcaat attaaaattc 420
gtaaatatag cgtaccaatg cctggaatct ttgatgatgt ggaaattgag gtggagggga 480
cgccgaatgg caagtaggga agaacgggtt tatttgagtg ttggttccaa tattcatccg 540
cgcgtccaaa atattcagca agcccttagc cgattacgag ccgtcaatgg ggtaaacgtg 600
attgacgaat ctcattggta tgagactcaa ccgtggggaa agcgtgatca ggccaatttt 660
tacaatgttt cggtatcctt aacgactaat ttgacaccag aagaactatt ggatgaatta 720
catacaattg agcaggcggg ccaccgccaa cgcttggttc actggggacc acgtacgatt 780
gatttggaca ttattttttg gggcgaccgg caaatcaaca cagcgacgct gacgattccg 840
catgcgcagg cagctaagcg caactttgtg ctactgccaa ctgctgaaat cgccaaaact 900
gatgtgttag ttggaccaca agtggcccaa ttgattgcgg ctaatcagga tcagagttgg 960
attaaaaaag taagaaatgt gagtgagtta g 991
<210> 3
<211> 1000
<212> DNA
<213> Lactobacillus plantarum YM4-3 (Lactobacillus plantarum YM 4-3)
<400> 3
gtgattgagt ggatacaggg acgattgaac aacgttatca ggacttatta gcccaactaa 60
atcaagccat gttagccaat aatcatcagc gtgttccgtt attacggcgc atcatggcac 120
atcttggcca ccctgaccat tattaccatg tgatccatat cgctggaact aatggcaaag 180
gctctacggg agccatgtta gccagtatcc tgcgggcgca agggtatcaa gttggccgct 240
tcagcagtcc cgcgattaat gatgcgcgtg aacaactgca atgcaatggg acgtggatca 300
gtccagcgga atttatcgat acgtatcgtg aaattctacc ggttctgcaa aatatgggac 360
tgacggctag cgatgtctcc atctttgaat ggttctttct cattagtgtc gtttggtttc 420
ggaatcaaaa cgtgcaatgg gcggtcattg aagccggttt gggtggcttg tatgatgcga 480
ctaacgcctt agccagtccc caactcacgg tatttactaa gattgccctc gatcatacca 540
ccattcttgg gcccacaatc accgcgattg cgcaaaataa gtcaaagatc attaagcccc 600
atacaacagc agtgacattg gctgaccaac acccagaagc cctggctgtt ttgcagaccg 660
aagcgctcaa tcaaggtgtt cggctagtga ccgctaagca cgcgcaactg acggtgactg 720
ggcaaacact cacgcaaacc gtcgttgatg cgcacagtca gctttttgat tggacgcaat 780
taacggtcgg actgagtggc acctatcagc tacaaaatct gcggttggtt ttaactgtgg 840
ttgcagtact acaacagcaa caagttaact tgacgaacag tgcggttcgc cgaggcttgc 900
aacaagtttc cttgccaggc cggttgaccg tgttacagga gcaacctgtc attattgccg 960
atggggcgca taatccggat ggcatggcag cactagtggc 1000
<210> 4
<211> 27
<212> DNA
<213> Artificial sequence (Artificial)
<400> 4
gcgtcgacac gcactttttt cggttcc 27
<210> 5
<211> 38
<212> DNA
<213> Artificial sequence (Artificial)
<400> 5
cctgtatcca ctcaatcacc taactcactc acatttct 38
<210> 5
<211> 38
<212> DNA
<213> Artificial sequence (Artificial)
<400> 5
agaaatgtga gtgagttagg tgattgagtg gatacagg 38
<210> 6
<211> 27
<212> DNA
<213> Artificial sequence (Artificial)
<400> 6
cggaattcgc cactagtgct gccatgc 27
<210> 7
<211> 25
<212> DNA
<213> Artificial sequence (Artificial)
<400> 7
ctaaaaatca gtttcatcaa gcaat 25
<210> 8
<211> 19
<212> DNA
<213> Artificial sequence (Artificial)
<400> 8
catcgcagcc gtggtcata 19
Claims (1)
1. A Lactobacillus plantarum (A)Lactobacillus plantarum) Genefol Application of KE in folic acid biosynthesis and genefol KE is shown in SEQ ID NO 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210212625.9A CN114634938A (en) | 2022-03-06 | 2022-03-06 | Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210212625.9A CN114634938A (en) | 2022-03-06 | 2022-03-06 | Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114634938A true CN114634938A (en) | 2022-06-17 |
Family
ID=81947815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210212625.9A Pending CN114634938A (en) | 2022-03-06 | 2022-03-06 | Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114634938A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112961878A (en) * | 2021-03-08 | 2021-06-15 | 昆明理工大学 | Application of gene of lactobacillus plantarum in folic acid biological generation |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070031486A1 (en) * | 2005-08-04 | 2007-02-08 | Squashic Steven A | Nutritional supplement for use under physiologically stressful conditions |
CN101939441A (en) * | 2007-12-06 | 2011-01-05 | 食品和营养托浦研究所基金会 | Increased folate production levels in lactobacillus fermenting melon juice |
US20140073598A1 (en) * | 2012-09-11 | 2014-03-13 | Jaymac Pharmaceuticals Llc | Multiple folate formulation and use thereof |
WO2015047199A2 (en) * | 2013-09-30 | 2015-04-02 | National Science And Technology Development Agency | A bacterial surrogate for testing of antimalarials: thya knockout, fola knockout, folp knockout, and folk knockout bacteria for testing of inhibition of antifolate pathway |
US20180166174A1 (en) * | 2016-08-02 | 2018-06-14 | Thomas J. Lewis | Disease Mitigation and Elimination Health Learning Engine |
CN109735556A (en) * | 2019-02-22 | 2019-05-10 | 昆明理工大学 | The purposes of Priming Glycosyltransferase Gene Involved |
CN109810991A (en) * | 2019-03-02 | 2019-05-28 | 昆明理工大学 | The purposes of dihydropteroate synthase gene folP |
CN111235169A (en) * | 2020-02-03 | 2020-06-05 | 昆明理工大学 | GTP cyclohydrolase I gene folE and application thereof |
CN112280795A (en) * | 2020-11-17 | 2021-01-29 | 昆明理工大学 | Use of glycosyltransferase genes |
CN112795527A (en) * | 2021-03-05 | 2021-05-14 | 昆明理工大学 | Use of dihydropterin aldolase gene |
CN112813085A (en) * | 2021-03-05 | 2021-05-18 | 昆明理工大学 | Use of pyrophosphatase gene |
CN112852844A (en) * | 2021-03-05 | 2021-05-28 | 昆明理工大学 | Application of hydroxymethyl dihydropterin pyrophosphokinase gene folK |
CN112961878A (en) * | 2021-03-08 | 2021-06-15 | 昆明理工大学 | Application of gene of lactobacillus plantarum in folic acid biological generation |
-
2022
- 2022-03-06 CN CN202210212625.9A patent/CN114634938A/en active Pending
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070031486A1 (en) * | 2005-08-04 | 2007-02-08 | Squashic Steven A | Nutritional supplement for use under physiologically stressful conditions |
CN101939441A (en) * | 2007-12-06 | 2011-01-05 | 食品和营养托浦研究所基金会 | Increased folate production levels in lactobacillus fermenting melon juice |
US20110159148A1 (en) * | 2007-12-06 | 2011-06-30 | Hendrikus Wegkamp | Increased folate production levels in lactobacillus fermenting melon juice |
US20140073598A1 (en) * | 2012-09-11 | 2014-03-13 | Jaymac Pharmaceuticals Llc | Multiple folate formulation and use thereof |
WO2015047199A2 (en) * | 2013-09-30 | 2015-04-02 | National Science And Technology Development Agency | A bacterial surrogate for testing of antimalarials: thya knockout, fola knockout, folp knockout, and folk knockout bacteria for testing of inhibition of antifolate pathway |
US20180166174A1 (en) * | 2016-08-02 | 2018-06-14 | Thomas J. Lewis | Disease Mitigation and Elimination Health Learning Engine |
CN109735556A (en) * | 2019-02-22 | 2019-05-10 | 昆明理工大学 | The purposes of Priming Glycosyltransferase Gene Involved |
CN109810991A (en) * | 2019-03-02 | 2019-05-28 | 昆明理工大学 | The purposes of dihydropteroate synthase gene folP |
CN111235169A (en) * | 2020-02-03 | 2020-06-05 | 昆明理工大学 | GTP cyclohydrolase I gene folE and application thereof |
CN112280795A (en) * | 2020-11-17 | 2021-01-29 | 昆明理工大学 | Use of glycosyltransferase genes |
CN112795527A (en) * | 2021-03-05 | 2021-05-14 | 昆明理工大学 | Use of dihydropterin aldolase gene |
CN112813085A (en) * | 2021-03-05 | 2021-05-18 | 昆明理工大学 | Use of pyrophosphatase gene |
CN112852844A (en) * | 2021-03-05 | 2021-05-28 | 昆明理工大学 | Application of hydroxymethyl dihydropterin pyrophosphokinase gene folK |
CN112961878A (en) * | 2021-03-08 | 2021-06-15 | 昆明理工大学 | Application of gene of lactobacillus plantarum in folic acid biological generation |
Non-Patent Citations (4)
Title |
---|
STOFILOVA,J.等: "Lactiplantibacillus plantarum strain LS/07 chromosome, complete genome" * |
WILBERT SYBESMA等: "Increased Production of Folate by Metabolic Engineering of Lactococcus lactis" * |
李书鸿: "植物乳杆菌YM-4-3菌株叶酸生物合成途径关键基因folP和folE的功能研究" * |
***坤;柳陈坚;罗义勇;杨恩;李晓然;: "发酵条件对植物乳杆菌叶酸合成的影响" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112961878A (en) * | 2021-03-08 | 2021-06-15 | 昆明理工大学 | Application of gene of lactobacillus plantarum in folic acid biological generation |
CN112961878B (en) * | 2021-03-08 | 2023-04-25 | 昆明理工大学 | Application of lactobacillus plantarum gene in folic acid biological generation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109810991B (en) | Application of dihydropteroate synthase gene folP | |
CN114107340B (en) | Mevalonate kinase gene RKMK and application thereof | |
CN110484572B (en) | Method for increasing yield of saccharomyces cerevisiae nerolidol | |
CN116286900B (en) | Acetic acid permease A gene RkAcpa and application thereof | |
CN111235169A (en) | GTP cyclohydrolase I gene folE and application thereof | |
CN112175848B (en) | Yeast strain for producing patchouli alcohol and construction method and application thereof | |
CN107937297B (en) | Multi-inhibitor stress tolerance saccharomyces cerevisiae, and preparation method and application thereof | |
CN115927029A (en) | Recombinant saccharomyces cerevisiae for producing cannabigerol acid and construction method and application thereof | |
CN114634938A (en) | Application of lactobacillus plantarum gene fol KE in folic acid biosynthesis | |
CN110079567B (en) | Application of recombinant escherichia coli for overexpression of fimH gene in fermentation production of amino acid | |
CN111471602A (en) | Construction method and application of mucor circinelloides engineering strain for efficiently synthesizing gamma-linolenic acid by using cellulose | |
CN112941119B (en) | Method for increasing yield of fatty acid ethyl ester of saccharomyces cerevisiae engineering bacteria | |
CN116926092B (en) | Pantothenate kinase gene RkPank and application thereof | |
CN110791466B (en) | Recombinant bacterium for synthesizing butanetriol oleate as well as construction method and application thereof | |
CN114525215B (en) | Recombinant strain for producing terpenoid, construction method thereof, method for producing terpenoid through fermentation and application of recombinant strain | |
CN116555054A (en) | Recombinant schizochytrium limacinum with high DHA yield, construction method and application thereof | |
CN109136120B (en) | Microorganisms and uses thereof | |
CN110628788A (en) | Construction method of monascus purpureus comp51725_ c0 gene overexpression strain | |
CN114277040A (en) | Construction method and application of bacterial strain for efficiently synthesizing beta-carotene | |
CN112852847A (en) | Recombinant saccharomyces cerevisiae strain and construction method and application thereof | |
CN117264793B (en) | Method for improving beta-carotene production of yarrowia lipolytica through molecular docking, engineering bacteria obtained by method, construction method and application of engineering bacteria | |
CN114456964B (en) | Recombinant yarrowia lipolytica for high yield of stigmasterol, construction method thereof, fermentation medium for producing stigmasterol and application | |
CN112779174B (en) | Saccharomyces cerevisiae genetically engineered bacterium for knocking out Cln3 gene, construction method and application thereof | |
CN114574515B (en) | Method for expressing protein by Chlamydomonas reinhardtii with strong stress resistance | |
CN113061541B (en) | Recombinant saccharomyces cerevisiae and application thereof in production of conjugated linoleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220617 |